Haviv Ilan President, CEO & Chairman. Yes. I think that happened exactly a week ago, and not a lot of change. We are excited about where we are. We are in the last year of a 6-yea ...

Andriy Kobolyev set at least four national records while leading one of Ukraine’s largest state-owned companies, Naftogaz of Ukraine. First, he became its youngest head — when he was appointed in ...

Reality shows that they need to produce them much faster than traditional production methods allow. While all of these factors are required by brands to be successful in their respective ...

The Chiefs can’t afford to miss with the ninth overall pick, and Rueben Bain Jr.’s historically short arm length raises serious questions about whether his pass-rush profile can deliver the star-level ...

I am increasing exposure to First Trust Energy AlphaDEX Fund ETF to protect against an oil and gas supply shock amid U.S.-Iran tensions. FXN offers up-to-mid stream oil and gas sector exposure with a ...

The Evo2 genomic language model can generate short genome sequences, but scientists say further advances are needed to write ...

This paper examines whether Chinese development finance is associated with faster progress toward Millennium Development Goal style targets in low- and middle-income countries. We combine AidData’s ...

In this way, prediction markets are the perfect technology for a low-trust society, simultaneously exploiting and reifying an environment in which believing the motives behind any person or action ...

Learn how prediction markets work, compare top platforms like Kalshi and Polymarket, and understand the regulatory shifts driving this $44B market.

EPFL researchers have developed a light-based method that can produce proteins that switch states, respond to signals, and even compute, using light and the cell cycle.

Xiong, S. , Sun, H. , Sun, T. , Li, Q. and Lu, H. (2026) Research on an Intelligent Algorithm for the Restoration of Fractured Aero Engine Wheel Disks. Journal of Computer and Communications, 14, 1-16 ...

A look at the biologics, gene therapies, and vaccines most likely to reshape care —and manufacturing—in the year ahead.